Nalaganje...
Breakthrough venous thromboembolic events in five patients with COVID‐19 on direct oral anticoagulants
WHAT IS KNOWN AND OBJECTIVE: Coronavirus disease 2019 (COVID‐19) is associated with increased risk of venous thromboembolism (VTE). Guidance for VTE prophylaxis continues to evolve, including addressing direct oral anticoagulants (DOACs) continued upon hospitalization. CASE SUMMARIES: We present 5 p...
Shranjeno v:
| izdano v: | J Clin Pharm Ther |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
John Wiley and Sons Inc.
2020
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7753371/ https://ncbi.nlm.nih.gov/pubmed/33217032 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jcpt.13311 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|